Form D · Other
Koronis Antiviral Partners II, L.P.
Seattle, WA · CIK 0001473954
Offering snapshot reported Oct 6, 2009 · SEC filing
- Reported sold
- $1.04M Offering amount: $4.5M
- Investors reported
- 43 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 22, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 6, 2009 | Initial | $1,044,840 | No comparison | 43 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-135013
Source: Form D, filed Oct 6, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Donald Elmer | Executive |
Issuer details
Industry: Other (See others in industry)
Address:
701 Fifth Avenue Suite 4970
Seattle, WA, 98104
Seattle, WA, 98104